A role for proteinase-activated receptor-1 in inflammatory bowel diseases
about
Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndromeEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsThrombin receptors and their antagonists: an update on the patent literatureFunctional GI disorders: from animal models to drug development.Regulatory network of inflammation downstream of proteinase-activated receptorsMandatory role of proteinase-activated receptor 1 in experimental bladder inflammationTranscription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation.Functional role of kallikrein 6 in regulating immune cell survival.Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivoHaemostatic system in inflammatory bowel diseases: new players in gut inflammation.Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells.Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model.Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitisProtective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells.Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.Clinical relevance of proteinase activated receptors (pars) in the gutTissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis.Inhibition of protease-activated receptor 1 ameliorates intestinal radiation mucositis in a preclinical rat model.Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injuryActivated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombinAnti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model.The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.The protein C pathway and pathologic processesThrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathwaysTargeting PAR1: Now What?The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation.Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1.
P2860
Q26862565-ADE6A7F2-669D-4AF4-8E4E-579E528A1B3CQ27023122-84820D39-F577-431E-91DE-A418182A94CEQ27027602-90EDE178-CE83-4D65-B8F2-23F5A1AA371CQ28281696-63BE6959-A345-4CCD-B512-1CD4DD5ED336Q30433078-6569226C-C56E-4C16-B243-9DBF3BF79229Q33280659-CDAE4D09-63D7-40BC-85E4-DA2295DD4654Q33280660-D6E9B75A-F202-4A9C-A819-AC3495144283Q33294523-02F8F0D8-0185-4B74-9234-7904CEA07CE1Q33862447-B063EE8D-8A28-4791-9D6B-8094794F12AEQ34014510-5A6D4AE6-D13E-4291-B372-779B56167724Q34579752-0E16A56F-45C6-4922-A899-C7D4F6A9EE48Q34676029-6AEDFE1E-FB73-497A-8E06-CF8291BADE50Q34700750-5703D8B1-A49E-45EC-9AEC-3CB0FC867B3AQ34983954-036FBEA6-B40A-4BA9-978F-3AB2334292C8Q35221859-DABDA11A-DB11-4E64-872D-0B2BD49371AFQ35458444-7CC38484-FDCB-4F48-ABA1-295B16B67E34Q35745630-1166406D-0DFD-49C9-B5AC-3FF06B44C171Q36124432-D4DEE7A8-7B11-4334-A483-A55B90B0CC1DQ36229495-94C982E2-2B5E-4CAF-AAF1-1943E4676B7EQ36293402-092594AF-DEB2-4F16-85F4-FD4F30F1D7EBQ36359579-CB4DA4BF-48C8-46DB-856C-1E0FB542548EQ36478416-EF7C446E-C3F0-48E0-A4DB-ECD9AEDD1A82Q36898582-49327506-3267-4287-9651-E44751DF2F81Q36950557-0965F244-38E8-478D-A06B-ECCE90B33175Q37024500-CBE22D8F-277C-4D04-A576-9633CFB3564EQ37561507-A5E6C7C0-F5E1-4E94-A810-B8111E5E4B99Q38629870-5E9B0020-01F8-4069-9B69-3B85913DBC56Q39338913-5A05BC50-C895-4F00-967C-368B546F735BQ41887469-8EDB264B-8A8E-4763-8573-913181F69FAAQ47588260-5292D7D6-412F-4203-8FEF-99980E59ABFFQ50320364-FDDA8949-AD53-4DE4-84D8-E1F9535E52A8Q51732026-1E187AF4-C155-42F7-B86A-2C53C7715A50
P2860
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
@en
A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
@nl
type
label
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
@en
A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
@nl
prefLabel
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
@en
A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
@nl
P2093
P2860
P356
P1476
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
@en
P2093
Andrea Mencarelli
Giovanni Rizzo
Giuseppe Cirino
John L Wallace
Laurie Cellars
Martin Steinhoff
Morley D Hollenberg
Nathalie Vergnolle
Nigel W Bunnett
Patricia Andrade-Gordon
P2860
P304
P356
10.1172/JCI21689
P407
P577
2004-11-01T00:00:00Z